Literature DB >> 15085400

Safe and permissible limits of hepatectomy in obstructive jaundice patients.

Tetsuya Takahashi1, Shinji Togo, Kuniya Tanaka, Itaru Endo, Yoshiro Fujii, Hiroshi Shimada.   

Abstract

The safe and permissible limits of hepatectomy in obstructive jaundice patients and the usefulness of preoperative portal embolization (PE) for increasing the limit for safe hepatectomy were examined. We classified 416 patients with hepatectomy performed over 9 years under the following headings: normal liver function (n = 242); chronic hepatitis (n = 71); liver cirrhosis (n = 64); and liver after relief of obstructive jaundice (n = 39). Hepatectomy was done after the total bilirubin level was reduced below 3 mg/dl by preoperative biliary drainage. Factors influencing the maximum total bilirubin level measured within 2 weeks after hepatectomy were investigated, and this level was taken to reflect the degree of surgical stress. PE was carried out in 18 patients with obstructive jaundice. The maximum total bilirubin, expressed as a logarithm, was significantly correlated with the percent of liver resected in all groups. Hepatectomy followed by a maximum total bilirubin of less than 8.5 mg/dl was accepted as safe, and hepatectomy followed by a bilirubin level of 14.4 mg/dl was deemed the maximum permissible resection. On the basis of these results, the safe and permissible limits of hepatectomy in patients with obstructive jaundice were 48.7% and 71.6%, respectively. PE decreased the maximum total bilirubin from 8.5 mg/dl to 3.9 mg/dl when 48.7% of the liver (a safe proportion in all cases) was resected; PE increased the safe limit of hepatectomy from 48.7% to 67.4% when a maximum posthepatectomy total bilirubin level of 8.5 mg/dl was accepted as safe.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15085400     DOI: 10.1007/s00268-004-7128-7

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  19 in total

1.  Early events in sepsis-associated cholestasis.

Authors:  P L Jansen; M Müller
Journal:  Gastroenterology       Date:  1999-02       Impact factor: 22.682

Review 2.  Postoperative jaundice.

Authors:  J T LaMont; K J Isselbacher
Journal:  N Engl J Med       Date:  1973-02-08       Impact factor: 91.245

3.  Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography.

Authors:  S B Heymsfield; T Fulenwider; B Nordlinger; R Barlow; P Sones; M Kutner
Journal:  Ann Intern Med       Date:  1979-02       Impact factor: 25.391

4.  A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease.

Authors:  Y Midorikawa; K Kubota; T Takayama; H Toyoda; M Ijichi; G Torzilli; M Mori; M Makuuchi
Journal:  Surgery       Date:  1999-09       Impact factor: 3.982

5.  Prediction of the safe limits of hepatectomy by combined volumetric and functional measurements in patients with impaired hepatic function.

Authors:  E Okamoto; A Kyo; N Yamanaka; N Tanaka; K Kuwata
Journal:  Surgery       Date:  1984-05       Impact factor: 3.982

6.  Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis.

Authors:  A Rimola; R Soto; F Bory; V Arroyo; C Piera; J Rodes
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

7.  Improved functional reserve of hypertrophied contra lateral liver after portal vein ligation in rats.

Authors:  Yasuhiko Nagano; Kaoru Nagahori; Masako Kamiyama; Yoshiro Fujii; Toru Kubota; Itaru Endo; Shinji Togo; Hiroshi Shimada
Journal:  J Hepatol       Date:  2002-07       Impact factor: 25.083

8.  Hepatic mitochondrial changes in experimental obstructive jaundice complicated by biliary infection.

Authors:  I Nagano; S Kato; Y Nimura; T Wakabayashi
Journal:  Hepatogastroenterology       Date:  1994-10

9.  [Liver failure after hepatic resection].

Authors:  H Shimada; A Matsuba; S Nimoto; H Fujita; G Nakagawara; S Tsuchiya
Journal:  Nihon Geka Gakkai Zasshi       Date:  1989-04

10.  Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.

Authors:  C H Su; S H Tsay; C C Wu; Y M Shyr; K L King; C H Lee; W Y Lui; T J Liu; F K P'eng
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.